|
Prior to joining Actis Biologics, Richard worked as a consultant with Arriva Pharmaceutical. Prior to Arriva Pharmaceuticals, he was the Director of Mfg Compliance for Transgenomic working on the Quality Assurance and manufacturing of Phosphoramidites - start material (synthetic nucleotides) to Biotech companies pursuing anti-sense clinical trials. He was hired into Transgenomic from Aviron where he was responsible for production technical support at Aviron’s Liverpool, England facility for the manufacture of its flu vaccine, Flumist. Prior to Aviron, Richard was the Growth Factor Purification Manager at Chiron Corporation, where he was responsible for the design and build-out of a new multi product facility for Chiron and was also responsible for the manufacture of a variety of products including PDGF (licensed in December 1996). His initial positions in Chiron were in Quality Assurance and Quality Control prior to moving to cGMP manufacture. | 